(Press-News.org) Los Angeles, CA – February 7, 2025 - The Terasaki Institute for Biomedical Engineering (TIBI) is pleased to announce their selection of Dr. Liangfang Zhang - Irwin Jacobs Chancellor’s Endowed Chair Professor at the University of California San Diego, and Dr. Aydogan Ozcan – Chancellor’s Professor, UCLA & Professor, Howard Hughes Medical Institute (HHMI), as the recipients of the inaugural Keith Terasaki Mid-Career Innovation Award. These awards will be presented at the 3rd Annual Terasaki Innovation Summit, to be held March 5-7, 2025, at the Terasaki Institute Research Headquarters in Woodland Hills, California.
About the Keith Terasaki Mid-Career Innovation Award
The Keith Terasaki Mid-Career Innovation Award honors the legacy of Dr. Keith Terasaki, a visionary leader and passionate philanthropist who made significant contributions to the Los Angeles innovation ecosystem. Created in memory of the former board chairman, this prestigious award celebrates scientists who embody Dr. Terasaki's spirit of translating groundbreaking research into real-world impact.
The award recognizes mid-career scientists who demonstrate innovative approaches that challenge existing scientific paradigms, showcase entrepreneurial spirit in research, and commit to transforming scientific discoveries into practical solutions with potential for meaningful societal change.
Recipients share a $10,000 cash prize ($5,000 each), deliver featured presentations at the Terasaki Innovation Summit, and receive national recognition for scientific excellence. Through this award, we continue Dr. Terasaki's vision of supporting visionary scientists dedicated to changing the world.
Dr. Liangfang Zhang
Dr. Zhang is amongst the top and extremely creative scientists in the field of nanoscience and nanomedicine. His expertise lies in the development of therapeutic nanoparticles to treat a variety of important diseases including cancers and bacterial infections, making Dr. Liangfang Zhang one of the leading authorities in this field of investigation. The value of his original contributions is well documented by his many publications in the field’s most preeminent journals, including Nature, Nature Nanotechnology, PNAS, Nano Lett., ACS Nano, Adv. Mater, etc. Dr. Zhang has already published 296 peer-reviewed articles with a total citation number of over 59800 and an h-index of 130. He also holds 132 issued and pending patents.
Among his many achievements, Dr. Zhang’s pioneering effort to develop a novel method of disguising nanoparticles as red blood cells (RBCs)—enabling them to evade the body’s immune system and deliver cancer-fighting drugs directly to a tumor—can be seen as the highlight of his dedicated career. His method involves collecting the membrane from an RBC and wrapping it like a powerful camouflaging cloak around a biodegradable polymeric nanoparticle filled with a cocktail of small-molecule drugs. Dr. Zhang invented this RBC membrane coating technique and demonstrated its effectiveness and robustness in a recent PNAS paper (2011, 108, 10980-10985; cited approximately 2,270 times). This work represents the first attempt to combine natural cellular membranes with synthetic nanomaterials to develop novel biomimetic drug delivery systems.
"I am deeply honored to receive the Keith Terasaki Mid-Career Innovation Award. Dr. Terasaki’s legacy of innovation and real-world impact is truly inspiring, and I am humbled to be recognized in his name. This award reinforces my commitment to advancing nanomedicine and developing transformative technologies that improve lives,” said Dr. Liangfang Zhang, Joan and Irwin Jacobs Chancellor’s Endowed Chair Professor at the University of California San Diego.
Dr. Aydogan Ozcan
Dr. Aydogan Ozcan is a pioneering scientist in biophotonics, computational microscopy, and diagnostic technologies, with a significant impact on biomedical applications such as pathology, microbiology, and global health. His groundbreaking research integrates photonics with computational techniques to develop cost-effective, highly sensitive imaging and sensing instruments. He has led the use of mobile phones for biomedical diagnostics, creating innovative tools like smartphone-based microscopes, flow cytometers, and pathogen sensors.
Dr. Ozcan's lab at UCLA has also revolutionized histopathology with AI-driven virtual staining, replacing traditional, time-consuming tissue staining methods with deep learning. This patented technology, commercialized through his company Pictor Labs, has the potential to transform pathology labs by enabling faster and more cost-effective disease diagnosis.
With over 330 journal publications, 42,900 citations, and an H-index of 106, Dr. Ozcan's contributions extend beyond research. He holds over 85 issued patents, many licensed by major companies, and has been recognized globally, including as a Technology Pioneer by the World Economic Forum. Additionally, his mentorship has shaped over 350 undergraduate researchers at UCLA, with a strong emphasis on diversity and STEM retention.
"It’s a huge honor to receive the Keith Terasaki Mid-Career Innovation Award.
Dr. Keith Terasaki’s legacy of innovation is truly inspiring, and this recognition strengthens my commitment to advancing biomedical optics and making transformative healthcare technologies accessible worldwide," said Dr. Aydogan Ozcan – Chancellor’s Professor, UCLA & Professor, Howard Hughes Medical Institute (HHMI).
Recognizing the two remarkable scientists for their exceptional work in the field of biomedical research, Professor Ali Khademhosseini, Director and CEO of the Terasaki Institute for Biomedical Innovation said, " At the Terasaki Institute, we are committed to advancing pioneering research that transforms scientific discovery into real-world solutions. The Keith Terasaki Mid-Career Innovation Award celebrates visionaries who redefine the frontiers of biomedical innovation. We are honored to recognize Dr. Zhang and Dr. Ozcan for their groundbreaking contributions, and we look forward to the profound impact their work will continue to have on science and society."
For more information, please contact:
Stewart Han
Terasaki Institute for Biomedical Innovation
Email: shan@terasaki.org
About the Terasaki Institute for Biomedical Innovation:
The Terasaki Institute for Biomedical Innovation (terasaki.org) is a non-profit research organization that invents and fosters practical solutions that restore or enhance the health of individuals. The Institute is made possible through an endowment from the late Dr. Paul I. Terasaki, a pioneer in the field of organ transplant technology.
###
END
Terasaki Institute for Biomedical Innovation announces recipients of inaugural Keith Terasaki Mid-Career Innovation Award
2025-02-07
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
The impact of liver graft preservation method on longitudinal gut microbiome changes following liver transplant
2025-02-07
Background and Aims
End-stage liver disease is associated with disruptions in gut microbiota composition and function, which may facilitate gut-to-liver bacterial translocation, impacting liver graft integrity and clinical outcomes following liver transplantation. This study aimed to assess the impact of two liver graft preservation methods on fecal microbiota and changes in fecal and breath organic acids following liver transplantation.
Methods
This single-center, non-randomized prospective pilot study enrolled liver transplant patients whose grafts were preserved using either static cold storage or ex situ normothermic machine perfusion (NMP). Fresh stool ...
Cardiovascular health risks continue to grow within Black communities, action needed
2025-02-07
DALLAS, Feb. 7, 2025 — The American Heart Association’s 2025 Heart Disease and Stroke Statistical Update reports that while progress has been made in reducing cardiovascular and cerebral health disparities, Black communities in the United States still face disproportionately higher risk of heart disease, stroke and hypertension. These gaps subsequently contribute to equally disproportionate high death rates, underscoring the urgent need for lifesaving intervention. As part of its nationwide Heart Month and Black History Month activations, the ...
ALS survival may be cut short by living in disadvantaged communities
2025-02-07
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.
ALS is a progressive, incurable condition that causes muscle wasting and loss of muscle control.
While most people survive with ALS around two to four years, some people can live significantly longer.
In the study of more than 1,000 patients with ALS seen between 2012 and mid-2024, people from the most disadvantaged neighborhoods had up to a 37% ...
No quantum exorcism for Maxwell's demon (but it doesn't need one)
2025-02-07
In a groundbreaking discovery, researchers from Nagoya University in Japan and the Slovak Academy of Sciences have unveiled new insights into the interplay between quantum theory and thermodynamics. The team demonstrated that while quantum theory does not inherently forbid violations of the second law of thermodynamics, quantum processes may be implemented without actually breaching the law. This discovery, published in npj Quantum Information, highlights a harmonious coexistence between the two fields, ...
Balancing the pressure: How plant cells protect their vacuoles
2025-02-07
Plants droop and shed their leaves when parched, but with a splash of water, their stems regain strength and their leaves unfurl. This dramatic transformation is a clear signal for us to reach for the watering can – and it demonstrates a delicate balance at the cellular level, which lies at the heart of plant’s rigidity.
The structural support of a plant depends on the unique balance between two elements: The strong, flexible cell wall provides structural support, while the vacuole, a large cellular compartment filled with water, acts like a water balloon, pressing against the cell wall. The delicate pressure balance between the inside and the ...
Electronic reporting of symptoms by cancer patients can improve quality of life and reduce emergency visits
2025-02-07
CHAPEL Hill, N.C.—People with metastatic cancer who regularly report their symptoms via a home-based electronic monitoring system experienced improved quality of life, clinical outcomes and well-being, as well as fewer emergency department visits than those who didn’t file reports. Both groups had similar overall survival rates, according to University of North Carolina Lineberger Comprehensive Cancer Center researchers and their colleagues.
The results from the national multicenter study appeared in Nature Medicine on Feb. 7.
“Doctors and nurses are often ...
DNA barcodes and citizen science images map spread of biocontrol agent for control of major invasive shrub
2025-02-07
New CABI-led research using publicly-shared DNA barcodes and citizen science images have provided new evidence on the establishment and spread of a biological control agent used for the control of the major invasive shrub Lantana camara.
Lantana camara was introduced as a garden and ornamental plant throughout the tropics and subtropics but is now pervasive throughout the Old World, invading woodlands, forestry, orchards, grasslands, and disturbed areas, where is displaces useful and indigenous plants.
Dr Matthew Cock, CABI Emeritus Fellow, and colleagues took DNA barcodes from the Barcode of Life Data System (BOLD) and citizen ...
Pregnancy complications linked to cardiovascular disease in the family
2025-02-07
Women who have experienced pregnancy complications have an increased risk of cardiovascular disease. Now, a new study from Karolinska Institutet published in the European Heart Journal shows that sisters of women with complicated pregnancies are also at higher risk, even if they had uncomplicated pregnancies. The findings suggest that genes and shared environmental factors may influence the association between pregnancy complications and cardiovascular disease risk.
It is well known that complications during pregnancy, such as high blood pressure and premature labour, increase the risk of cardiovascular disease later in life. However, it is unknown whether ...
Pancreatic cancer immune map provides clues for precision treatment targeting
2025-02-07
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to macrophage-based therapies.
The study which is published in Nature Communications was led by Associate Professor Shivan Sivakumar from the University of Birmingham and Associate Professor Rachael Bashford-Rogers at the University of Oxford and provides the most detailed immune map for pancreatic cancer. The findings suggest that some tumour cells ...
How neighborhood perception affects housing rents: A novel analytical approach
2025-02-07
Housing rents usually correlate with factors such as the building’s age, facilities, and location. Yet not all rentals with similar physical factors charge the same rent. Psychological factors such as the subjective perceptions of the neighborhood matter as well.
Considering these perception variables, an Osaka Metropolitan University team has developed a method with almost 75% accuracy in explaining housing prices in Osaka City.
The team led by Graduate School of Human Life and Ecology student Xiaorui Wang and Professor Daisuke Matsushita used existing Osaka City property datasets and incorporated additional information on the physical factors (sky, vegetation, and buildings) of ...